Ebixa takes on Alzheimer’s market leaders

November 9, 2005
Sales and Marketing

Lundbeck's Alzheimer's treatment Ebixa will compete directly with the leading treatments for the moderate form of the disease following an …

New Aptivus launched in Europe for resistant HIV

November 9, 2005
Sales and Marketing

Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been approved by the EMEA.The prevalence of drug-resistant HIV is …

UK approval for severe asthma treatment Xolair

November 9, 2005
Sales and Marketing

Novartis has received UK approval for Xolair, its novel monoclonal antibody treatment for severe persistent allergic asthma.The first drug in …

Tarceva receives approval for pancreatic cancer in the US

November 8, 2005
Sales and Marketing

Roche and Genentech's Tarceva has been approved in the US for the treatment of pancreatic cancer – one of the …

Pharma’s changing salesforces

November 8, 2005
Sales and Marketing

The traditional salesforce model has served the industry well for 30-40 years and has been one of the biggest drivers …

US acquisitions a coup for Cambridge Antibody

November 8, 2005
Research and Development

Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …

Industry’s European price ‘free riding’ claim refuted

November 8, 2005
Sales and Marketing

Long-standing claims that the US has been burdened with high medicines prices because of 'free riding' by European countries have …

NHS clinical leaders oppose mergers

November 8, 2005

More than three quarters of lead clinicians believe proposed mergers of Primary Care Trusts will harm patient care, according to …

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005
Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …

Marketers and levels of leadership

November 7, 2005
Sales and Marketing

Trends come and go in the pharma industry – just like in any other – but one which has stuck …

Prescribing powers proposed for new NHS support workers

November 4, 2005

Around 3,000 new healthcare support workers will provide clinical care across primary and secondary care, according to the government's latest …

NICE unveils fast track process

November 3, 2005
Sales and Marketing

Cancer drugs will be the first treatments to benefit from changes designed to speed up the way NICE makes its …

200,000 quitters to boost NRT sales

November 3, 2005
Sales and Marketing

Manufacturers of nicotine replacement therapy products can expect sales to rise when England's partial smoking ban is introduced.The government anticipates …

Radical change for NHS in Scotland

November 3, 2005

Healthcare services across Scotland are to focus on preventative care as part of wide-ranging changes to NHS priorities in the …

Government retreat on handing over PCT services

November 3, 2005

The government has retreated on plans for a mandatory opening up of primary care services to alternative providers.Health secretary Patricia …

Don’t blush…look before you flush’

November 3, 2005
Medical Communications

Bowel Cancer UK has been launched with a new campaign to promote personal awareness of the disease that kills 16,000 …

Galliard wins GSK and Pfizer accounts

November 3, 2005
Medical Communications

Galliard Healthcare Communications has won the global PR account for GlaxoSmithKline's Avodart and been appointed by Pfizer to handle UK …

Tamiflu’s frontline status a mixed blessing for Roche

November 3, 2005
Sales and Marketing

Sales of Roche's Tamiflu have rocketed as governments around the world prepare for a potential pandemic, but its status as …

Waking up to new ways of training

November 3, 2005
Business Services

From sales forecasts to the marketing mix, from business information to regulatory project management, there are as many training courses, …

GSK inspires more confidence than shaky AstraZeneca

November 1, 2005
Research and Development

The UK's two pharma giants have posted strong growth in the third quarter, but investor doubts about AstraZeneca's long-term prospects …

The Gateway to Local Adoption Series

Latest content